| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Wei Lin is a Chief Medical Officer at ERAS with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $18.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | RVMD Revolution Medicines, Inc. | Chief Medical Officer | Sell | 2,160 | $45.82 | $98,981.78 | -2.4% | +76.7% | - | |
| Jun 16, 2025 | RVMD Revolution Medicines, Inc. | Chief Medical Officer | Sell | 2,173 | $39.83 | $86,550.59 | -2.3% | +16.2% | +293.7% | |
| Jun 17, 2024 | RVMD Revolution Medicines, Inc. | Chief Medical Officer | Sell | 5,589 | $37.39 | $208,954.27 | -7.3% | +20.1% | +5.5% |